Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive Dr. Daniel R. Karlin and former Google AI/ML industry veteran Bradford Cross added to MindMed executive team NEW YORK, Feb. 26, 2021 /CNW/ — Mind Medicine (MindMed) Inc. (NEO: MMED, OTCQB: MMEDF, DE: MMQ) (“ MindMed“), a leading psychedelic medicine biotech…


Previous articlePurging the Pain: Hurting As Healing
Next articleMindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company